MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients-Reference-Cited by-同舟云学术

MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients

Published:2012-06-01 Issue:5 Volume:29 Page:3055-3062
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Hussein Yousri M.,Morad Fouad E.,Gameel Magda A.,Emam Wafaa A.,El Sawy Wael H.,El Tarhouny Shereen A.,Bayomy Eman S.,Raafat Nermin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-012-0257-1.pdf

Reference38 articles.

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–67.

2. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:41–6.

3. Forns X, Navasa M, Rodes J. Treatment of HCV infection in patients with advanced cirrhosis. Hepatology. 2004;40:498.

4. Baker DE. Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C. Rev Gastroenterol Disord. 2003;3:93–109.

5. Delhem N, Carpentier A, Morales O, et al. Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response. Bull Cancer. 2008;95:1219–25.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy;World Journal of Gastrointestinal Oncology;2021-09-15

2. Epigenetic Biomarkers in Liver Cancer;Methods in Molecular Biology;2014-11-08